- Home
- UPS vs BMY Comparison
UPS vs BMY Comparison
Compare UPS & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UPS | BMY |
|---|---|---|
| Founded | 1907 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.0B | 114.0B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | UPS | BMY |
|---|---|---|
| Price | $116.31 | $61.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 15 |
| Target Price | ★ $110.95 | $61.93 |
| AVG Volume (30 Days) | 5.7M | ★ 11.5M |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | ★ 5.76% | 4.11% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.56 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.79 | N/A |
| Revenue Next Year | $4.30 | N/A |
| P/E Ratio | $17.36 | ★ $17.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $82.00 | $42.52 |
| 52 Week High | $123.70 | $63.33 |
Technical Indicators
Market Signals| Indicator | UPS | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 56.35 | 63.95 |
| Support Level | $98.55 | $59.23 |
| Resistance Level | $122.41 | $62.05 |
| Average True Range (ATR) | 2.41 | 1.30 |
| MACD | -0.71 | -0.03 |
| Stochastic Oscillator | 26.16 | 64.01 |
Price Performance
Historical ComparisonAbout UPS United Parcel Service Inc.
As the world's largest parcel delivery company, UPS manages a massive fleet of more than 500 planes and 100,000 vehicles, along with many hundreds of sorting facilities, to deliver an average of about 22 million packages per day to residences and businesses across the globe. UPS' domestic US package operations generate around 65% of total revenue, while international package makes up 20%. Air and ocean freight forwarding and contract logistics make up the remainder.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.